Dormant
PCT · PureCycle Technologies, Inc.
Last analysed ·
Resolved Graded and closed 2026-06-18 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.
Current thesis
Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM TOHCELLO Japan packaging deal re-lights offtake, but structure stays broken with no confirmed base — a floor has to form before the loaded ~41%-of-float short base becomes squeeze fuel.
Kill line
A weekly close below $7 confirms the post-dilution downtrend with no base and opens the $4.93 52-week low; secondarily, another below-market raise or Q2 output stalling under the ~8M-lb/quarter pace breaks the commercial-ramp thesis.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for PCT —
As of 19 September 2026, the latest FrontierPicks analysis for PureCycle Technologies, Inc. (PCT): Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM TOHCELLO Japan packaging deal re-lights offtake, but structure stays broken with no confirmed base — a floor has to form before the loaded ~41%-of-float short base becomes squeeze fuel.
Kill line: A weekly close below $7 confirms the post-dilution downtrend with no base and opens the $4.93 52-week low; secondarily, another below-market raise or Q2 output stalling under the ~8M-lb/quarter pace breaks the commercial-ramp thesis.
Next dated event on file: — catalyst in 4d.
Current Thesis
PureCycle Technologies’ remaining recovery case rests on commercial resin shipments restoring production growth; confirmation requires a weekly reclaim of $7 and third-quarter output above the first-quarter record of 8.4 million pounds before a weekly close below $5.72. This is a prospective repair case: the earlier $7 invalidation already fired at the August 14, 2026 weekly close of $6.95, as documented in the September 5 note.
The original squeeze narrative is dead — its August 14 structural break remains unrepaired at the September 18, 2026 reference close of $5.72. The shares were down 31.4% over three months and 62.2% below their 52-week high in that dated price series. The narrower operating case remains unconfirmed: PureCycle’s August 6 results reported second-quarter production of 4.5 million pounds after 8.4 million pounds in the first quarter.
The positioning update does not establish forced covering. These observations are too few to establish whether convertible hedging explains the decline; the previous note’s explanation remains an unverified hypothesis. Benzinga short-interest calendar
Bullish and bearish views on PureCycle Technologies, Inc.
The model's bull view on PureCycle Technologies, Inc. (PCT), in brief: Commercial qualification reached customer shipments. The bear view: Production recovery remains unmeasured. The August 6, 2026 release reported second-quarter output of 4.5 million pounds and revenue of $4.512 million. Planned downtime explains the interruption, but a subsequent quarterly production figure is missing from the verified evidence.… Both cases follow in full.
Bull Case
- Commercial qualification reached customer shipments. PureCycle’s August 6, 2026 results reported initial commercial PureFive deliveries to Procter & Gamble, production of select Downy caps and a third-quarter retail timetable for Tide caps. A disclosed delay beyond September 30 would invalidate that retail timetable; shipments alone do not establish profitable production.
- The turnaround addressed operating constraints. The August 6, 2026 release reported more than 170 reliability and production-rate projects during planned downtime. The repair hypothesis requires subsequent output to exceed the first-quarter 8.4-million-pound record; third-quarter output at or below that figure would fail this dossier’s recovery test.
- The financing timetable was extended. The August 28, 2026 credit-agreement amendment extended the $200 million revolving facility’s maturity to September 30, 2028. Reported June 30 liquidity was $236.9 million, including restricted cash; neither the maturity extension nor that historical balance demonstrates operating breakeven.
Bear Case
- Production recovery remains unmeasured. The August 6, 2026 release reported second-quarter output of 4.5 million pounds and revenue of $4.512 million. Planned downtime explains the interruption, but a subsequent quarterly production figure is missing from the verified evidence.
- Financing added dilution and obligations. The June 15, 2026 financing filing disclosed 19,854,000 common shares issued at the company’s offering price of $8.21 and $287.5 million of convertible notes bearing 4.75% interest. Those are completed financing terms, not evidence that commercial revenue covers operating requirements.
- Short interest does not establish demand. Benzinga’s August 31, 2026 settlement data show 38.06% of its stated float short and 16.9 days to cover. The latter describes reported short interest relative to average volume; it does not establish a covering deadline or a future price rise. Benzinga short-interest calendar
Setup & Price Structure
The September 18, 2026 adjusted reference close of $5.72 was below the September 4 close of $6.39 recorded in the prior note. The 14-period relative strength index was 31.2 on September 18. A current moving-average value and a full intervening price sequence are missing, so neither a rising-average support claim nor a confirmed higher-low claim is supported.
The research threshold for the prospective repair case is a weekly close below $5.72, using the September 18 market close as an explicit reference rather than claiming an established support shelf. A weekly close above the previously broken $7 threshold would satisfy the price component of recovery; the operating component still requires third-quarter output above 8.4 million pounds. The earlier failure is not erased by introducing this narrower test.
Catalyst Calendar (next 30 days)
- 2026-09-24 — Short-interest publication. FINRA schedules publication for the September 15 settlement date on September 24, correcting the prior note’s estimated September 25 date. It updates the reported short count without identifying holders’ motives. FINRA reporting calendar
- 2026-09-30 — Tide retail-window endpoint. PureCycle’s August 6, 2026 update placed Tide-cap retail availability in the third quarter. September 30 is the end of that stated window, not a scheduled announcement; no shelf-level confirmation is established by the evidence available here.
- 2026-10-09 — Short-interest publication. FINRA schedules publication of September 30 settlement data for October 9. This supplies a subsequent observation, but does not by itself distinguish directional bearish exposure from convertible hedging. FINRA reporting calendar
- ~2026-11-05, estimated — Third-quarter results. Outside the next 30 days, this is the operating event on which the recovery case turns. MarketBeat estimates November 5 from past reporting schedules; the date is unconfirmed. The report tests production against the first-quarter record and management’s second-half 2026 Ironton site-level cash-breakeven goal. MarketBeat earnings record
What Would Change Our Mind
Failure to retain the September 18 reference close would end the prospective repair case: a weekly close below $5.72 is the published price invalidation. Separately, third-quarter output at or below the first-quarter record of 8.4 million pounds would fail the operating confirmation test. A company statement moving Ironton site-level cash breakeven beyond the second half of 2026 would invalidate the timetable reiterated with the August 6 results.
Evidence sufficient to overturn the failed-squeeze assessment would combine a weekly reclaim of $7 with reported third-quarter production above 8.4 million pounds. A lower short count alone would not meet that test: the August 14 and August 31 observations do not identify the reason for covering.
Correlation Notes
This remains a single-company setup centred on the Ironton production figures and customer-shipment milestones disclosed August 6, 2026. No dated peer-return series or measured correlation is available to support a group-move thesis. The September 18 three-month price decline of 31.4% describes PureCycle’s own market performance; it does not establish exposure to artificial-intelligence infrastructure or rare-earth demand.
Notes
- Zero AI exposure — an advanced polypropylene-recycling name repeatedly swept into AI momentum and short-interest screens. Cohort correlation is a screening artifact.
- GAAP results are dominated by non-cash marks (Q2: $52.5M warrant fair value, $34.5M debt extinguishment); GAAP EPS is not comparable to adjusted.
- first redemption date 2029-07-06.
- Warrants strike $11.50, expire 2027-03-17; 20 of 30 daily closes at or above $14.38 arms a forced $0.01 redemption.
- Short interest is published on roughly a two-week lag, so any reading describes positioning about two weeks before its publication date.
- Former Hindenburg Research target (2021); activist short-report headline risk recurs in this name.
Related · shared themes
EGO
Eldorado Gold Corporation
Eldorado Gold’s Skouries expansion thesis now hinges on fourth-quarter 2026 commercial production after first concentrate on September 8. Delivery before a weekly close below $40 would validate the case; a delay into 2027 would contradict the operating schedule.
FBIZ
First Business Financial Services, Inc.
First Business Financial Services’ earnings re-rating depends on Q3 sustaining its 3.78% margin and exceeding $19.8 million in pre-tax pre-provision earnings. The thesis fails on a weekly close below $68 or deterioration below those Q2 operating benchmarks.
FSM
Fortuna Mining Corp.
Fortuna Mining’s gold-supported cash generation funds its mine-growth story, but the September 11 retreat weakens the recovery case. A weekly close above $13.66 before a weekly close below $11.00 would confirm the equity thesis.
IAG
IAMGold Corporation
IAMGOLD’s margin-expansion case depends on Côté lowering costs as gold support weakens. Q3 all-in sustaining costs within the published $2,000–$2,150 per-ounce range and retained annual production guidance would confirm the case before a weekly close below $18.50 invalidates it.